# Acarbose Cardiovascular Evaluation Trial

> **NCT00829660** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 6526 (actual)

## Conditions studied

- Coronary Heart Disease
- Acute Coronary Syndrome
- Impaired Glucose Tolerance
- Type 2 Diabetes Mellitus (T2DM)

## Interventions

- **DRUG:** Acarbose
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT00829660
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-17
- **Primary completion:** 2017-04-11
- **Final completion:** 2017-04-18
- **Target enrollment:** 6526 (ACTUAL)
- **Last updated:** 2017-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00829660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00829660, "Acarbose Cardiovascular Evaluation Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00829660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*